Angiograft


Angio-Graft LLC specializes in innovative, off-the-shelf, cell-free vascular grafts for regenerative medicine. Their technology aims to reduce healthcare costs and improve patient outcomes by providing customizable, biologically functional blood vessels that attract the patient's own cells and remodel into natural tissue. Founded in 2015 in Buffalo, NY, the company focuses on developing acellular tissue-engineered vessels for cardiovascular disease treatment, offering off-the-shelf solutions that match patient needs.

Industries

biotechnology
health-care
medical

Nr. of Employees

small (1-50)

Angiograft

Amherst, New York, United States, North America


Products

Acellular tissue-engineered vascular grafts (off-the-shelf)

Implantable collagen-based vascular grafts manufactured without donor cells and functionalized to reduce clotting and promote host cell repopulation, intended for arterial and venous replacement.


Services

Manufacture and supply of off-the-shelf acellular vascular grafts

Production and provision of pre-made acellular vascular grafts intended for arterial and venous replacement and sized to match patient anatomy.

Development, testing and optimization of tissue-engineered vascular grafts

R&D and preclinical testing services focused on design iteration, material characterization and performance evaluation of vascular graft constructs.

Expertise Areas

  • Vascular tissue engineering
  • Regenerative medicine (cell-free approaches)
  • Biomaterials development
  • Scaffold functionalization and surface engineering
  • Show More (3)

Key Technologies

  • Acellular scaffold technology
  • Collagen-based biomaterials
  • Surface functionalization with antithrombotic and cell-adhesive proteins
  • Self-cellularizing (host cell recruitment) scaffold approaches
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.